Table 2 Seropositivity for CVBD according to the epidemiological variables analyzed
From: Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study
Epidemiological variable | CVBD | |||||
|---|---|---|---|---|---|---|
Positive/Total (%) | ||||||
An | Bb | Ec | Di | Li | ||
Age (years) | <1 | 2/17 (11.8) | 1/15 (6.7)** | 6/15 (40)** | 0/15 (0) | 0/14 (0) |
1-3 | 12/369 (3.2) | 1/361 (0.3) | 7/362 (1.9) | 2/361 (0.5) | 60/370 (16.2) | |
3-7 | 7/269 (2.6) | 0/261 (0) | 12/261 (4.6) | 2/262 (0.8) | 50/270 (18.5) | |
>7 | 7/307 (2.3) | 2/305 (0.6) | 23/307 (7.5) | 6/305 (2) | 44/327 (13.5) | |
Unknown | 2/14 (14.3) | 0/14 (0) | 0/14 (0) | 2/14 (14.3) | 2/14 (14.3) | |
|  | p value | p = 0.14 | p = 0.001 | p < 0.001 | p = 0.3 | p = 0.14 |
Sex | Male | 21/531 (4) | 3/526 (0.6) | 23/528 (4.4) | 9/527 (1.7) | 94/546 (17.2) |
Female | 9/445 (2) | 1/430 (0.2) | 25/431 (5.8) | 3/430 (0.7) | 62/449 (13.8) | |
|  | p value | p = 0.08 | p = 0.16 | p = 0.4 | p = 0.14 | p = 0.16 |
Clinical signs | Asymptomatic | 9/433 (2.1) | 0/416 (0) | 7/417 (1.7) | 2/416 (0.5) | 19/449 (4.2) |
Symptomatic | 19/506 (3.8) | 3/503 (0.6) | 38/505 (7.5)** | 9/504 (1.8) | 133/513 (25.9)** | |
Unknown | 2/37 (5.4) | 1/37 (2.7) | 3/37 (8.1) | 1/37 (2.7) | 4/33 (12.1) | |
|  | p value | p = 0.13 | p = 0.11 | p < 0.001 | p = 0.07 | p < 0.001 |
Place of abode | Indoor | 6/360 (1.7) | 0/346 (0) | 14/346 (4) | 2/346 (0.6) | 26/354 (7.3) |
Outdoor | 18/357 (5)* | 1/355 (0.3) | 22/355 (6.2) | 5/355 (1.4) | 86/362 (23.8)** | |
Mixed | 5/256 (2) | 3/252 (1.2) | 12/255 (4.7) | 5/253 (2) | 43/276 (15.6) | |
Unknown | 1/3 (5.2) | 0/3 (0) | 0/3 (0) | 0/3 (0) | 1/3 (5.2) | |
|  | p value | p = 0.01 | p = 0.07 | p = 0.23 | p = 0.28 | p < 0.001 |